Second Opinion™

Blood Tests Designed to Minimize Unnecessary Biopsies

Chronix Biomedical is offering a laboratory developed blood test that is being used as a supplementary evaluation to prostate cancer screening. This evaluation test assists clinicians in the decision making process of whether a patient with an elevated PSA, suspicious MRI or DRE should be sent for a tissue biopsy. The Second Opinion™ Prostate Cancer Evaluation Test is designed to bring down the unacceptably high number of false positives associated with PSA testing.